tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Hoang, 51 are a BUY (73.91%), 13 are a HOLD (18.84%), 5 are a SELL (7.25%).
Analyst David Hoang, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 59.54% that have a potential upside of 33.73% achieved within 214 days.
David Hoang’s has documented 129 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings at 30-Jun-2026.
Analyst best performing recommendations are on MLNT (MELINTA THERAPEUTICS).
The best stock recommendation documented was for SYRE (SPYRE THERAPEUTICS) at 9/26/2025. The price target of $43 was fulfilled within 147 days with a profit of $26.76 (164.78%) receiving and performance score of 11.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Oct-2023
$16
$-0.7 (-4.19%)
$22
2 years 9 months 5 days ago
(05-Oct-2023)
1/2 (50%)
$0.05 (0.31%)
1
Buy Since 14-Sep-2020
2 years 11 months 1 days ago
(09-Aug-2023)
0/2 (0%)
$88 (107.32%)
Buy Since 29-Dec-2021
$15
$-1.7 (-10.18%)
$15
3 years 13 days ago
(27-Jun-2023)
3/3 (100%)
$9.77 (186.81%)
107
Buy Since 13-Mar-2023
$5
$-11.7 (-70.06%)
3 years 3 months 27 days ago
(13-Mar-2023)
1/1 (100%)
$0.05 (1.01%)
1
Buy Since 05-Sep-2019
$13
4 years 1 months 27 days ago
(13-May-2022)
2/2 (100%)
$-34.2 (-72.46%)
621
Which stock is David Hoang is most bullish on?
Which stock is David Hoang is most reserved on?
What Year was the first public recommendation made by David Hoang?
